MENU
BCDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioCardia (BCDA) Ownership - Who owns BioCardia?
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs... Show more
Profile
Industry
N/A
Address
320 Soquel Way
Phone
+1 650 226-0120
Employees
20
Web
https://www.biocardia.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.32M
P/E Ratio
N/A
Total Cash
4.93M
Projected Growth
N/A
Total Debt
1.05M
Revenue
71K
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash/Share
1.08
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
BCDA
Capitalization
8.32M
P/E Ratio
N/A
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash
4.93M
Total Cash/Share
1.08
Total Debt
1.05M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
71K
ROE
N/A
Book Value
2.75M
P/B Ratio
9.94
Cash Flow
N/A
Earnings
-4.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
1.78
Current Revenue Per Employee
150.00
Dividends Per Share - Security
N/A
EBITDA
-7.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-154.22
Shares Held By Institutions
347K
Shares Outstanding - Current
4.58M
Total Liabilities
3.51M
Total Volume MTD
N/A
Value
-1
Gain YTD
-16.743
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage regenerative medicine company, which develops novel therapeutics for cardiovascular diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
320 Soquel Way
Phone
+1 650 226-0120
Employees
20
Web
https://www.biocardia.com